These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 32123924)
1. High Prevalence of Buprenorphine in Prenatal Drug Screens in an Appalachian City. Alexander C; Breuel K; Olsen M South Med J; 2020 Mar; 113(3):111-115. PubMed ID: 32123924 [TBL] [Abstract][Full Text] [Related]
2. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. Johnson S; Martin PR Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626 [TBL] [Abstract][Full Text] [Related]
3. Maternal buprenorphine treatment and infant outcome. Jansson LM; Velez ML; McConnell K; Spencer N; Tuten M; Jones H; Rios R; King VL; Gandotra N; Millio L; DiPietro JA Drug Alcohol Depend; 2017 Nov; 180():56-61. PubMed ID: 28869859 [TBL] [Abstract][Full Text] [Related]
4. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine. O'Connor AB; Kelly BK; O'Brien LM Drug Alcohol Depend; 2017 Nov; 180():200-203. PubMed ID: 28917206 [TBL] [Abstract][Full Text] [Related]
5. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456 [TBL] [Abstract][Full Text] [Related]
6. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. O'Connor AB; Collett A; Alto WA; O'Brien LM J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660 [TBL] [Abstract][Full Text] [Related]
7. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191 [TBL] [Abstract][Full Text] [Related]
8. Quantitation of Total Buprenorphine and Norbuprenorphine in Meconium by LC-MS/MS. Marin SJ; McMillin GA Methods Mol Biol; 2016; 1383():59-68. PubMed ID: 26660174 [TBL] [Abstract][Full Text] [Related]
9. Could prenatal food insecurity influence neonatal abstinence syndrome severity? Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365 [TBL] [Abstract][Full Text] [Related]
10. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure. Nguyen L; Lander LR; O'Grady KE; Marshalek PJ; Schmidt A; Kelly AK; Jones HE Am J Addict; 2018 Mar; 27(2):92-96. PubMed ID: 29473258 [TBL] [Abstract][Full Text] [Related]
11. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects. Wachman EM; Saia K; Miller M; Valle E; Shrestha H; Carter G; Werler M; Jones H Clin Ther; 2019 Sep; 41(9):1681-1689. PubMed ID: 31358302 [TBL] [Abstract][Full Text] [Related]
12. Provision of Buprenorphine to Pregnant Women by For-Profit Clinics in an Appalachian City. Walker JJ; Olsen ME South Med J; 2018 Oct; 111(10):575-578. PubMed ID: 30285261 [TBL] [Abstract][Full Text] [Related]
13. Buprenorphine and methadone for opioid addiction during pregnancy. Mozurkewich EL; Rayburn WF Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488 [TBL] [Abstract][Full Text] [Related]
14. Detoxification from opiate drugs during pregnancy. Bell J; Towers CV; Hennessy MD; Heitzman C; Smith B; Chattin K Am J Obstet Gynecol; 2016 Sep; 215(3):374.e1-6. PubMed ID: 26996987 [TBL] [Abstract][Full Text] [Related]
15. Prenatal treatment for opioid dependency: observations from a large inner-city clinic. Saia K; Bagley SM; Wachman EM; Patel PP; Nadas MD; Brogly SB Addict Sci Clin Pract; 2017 Jan; 12(1):5. PubMed ID: 28086944 [TBL] [Abstract][Full Text] [Related]
16. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042 [TBL] [Abstract][Full Text] [Related]
17. Development, Implementation, and Evaluation of a Pilot Parenting Educational Intervention in a Pregnancy Buprenorphine Clinic. Giles AC; Ren D; Founds S Nurs Womens Health; 2016; 20(3):258-67. PubMed ID: 27287352 [TBL] [Abstract][Full Text] [Related]
18. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder. Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421 [TBL] [Abstract][Full Text] [Related]
19. Implications of Tennessee's Opioid Legislation for Neonatal Abstinence Syndrome. Shearer JN; Erwin PC; Davis SK; Anderson JG; Lindley LC Policy Polit Nurs Pract; 2019 Aug; 20(3):153-162. PubMed ID: 31390304 [TBL] [Abstract][Full Text] [Related]
20. Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013. Warren MD; Miller AM; Traylor J; Bauer A; Patrick SW; MMWR Morb Mortal Wkly Rep; 2015 Feb; 64(5):125-8. PubMed ID: 25674995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]